Latest fund size
Undisclosed
Announced
October 17, 2026
Global HQ
United States
Members only
Check size
Undisclosed
Members only
Stage focus
Seed, Series A
Members only
Regions of investment
North America
Members only
NeoGenesis Capital is a US-based venture capital firm investing in programmable biology at the intersection of AI and synthetic biology. The firm pursues a concentrated, single-ecosystem strategy centered on Colossal Biosciences, investing in Colossal itself and in companies built on or incubated from its platform, targeting longevity, fertility, agriculture, environmental remediation, and AI-native genetic design.
Peter H. Diamandis, MD, Co-Founder and Partner
Yianni Psaltis, PhD, Co-Founder and Managing Partner
Members only
Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.
NeoGenesis Capital invests in programmable biology built at the intersection of superintelligence and synthetic biology, targeting longevity, fertility, agriculture, environmental remediation, and AI-native genetic design.
Rather than investing broadly across biotech, the firm runs a deliberately concentrated, single-ecosystem strategy anchored to Colossal Biosciences, backing Colossal itself as well as companies built on or spun out of its platform, including drought- and disease-resistant crops, pathogen-tracking tools, microplastic-degrading enzymes, and artificial womb technology for endangered-species conservation.
Members only
What the fund looks for in founders and which sectors it backs.
NeoGenesis Capital announced the initial close of its first fund, NeoGenesis Capital I, L.P., in October 2026.
The fund's size and check size have not been disclosed.
Members only
Fund size, LPs and track record.
Leadership
NeoGenesis Capital was co-founded by Peter H. Diamandis, MD, who serves as Co-Founder and Partner and is also founder and executive chairman of XPRIZE, and Yianni Psaltis, PhD, Co-Founder and Managing Partner, who holds a doctorate in cancer biology from Georgetown University.
Notable Investments
Members only
Leadership, investment strategy, notable investments and exits.
